Biotech Values

[DewDiligence]

WPI’s PR on the preliminary injunction:

http://finance.yahoo.com/news/Watson-Confirms-Court-Grants-prnews-282360757.html?x=0&.v=1

Nothing of particular interest here other than the low-key tenor of the language. From the start of this litigation (and even before that), WPI has given the impression of being a somewhat reluctant partner of Amphastar’s, e.g. in the prior PR claiming that WPI is fully indemnified by Amphastar for liabilities arising from the Lovenox program.